Samphire Neuroscience
Brain-powered menstrual relief
London, UK
A medtech startup focusing on women's health through brain-based innovation.
How We Help
Problem Statement
Transforming women's health by providing drug-free, non-invasive solutions for menstrual-related pain and mood symptoms.
Core Technology
Neuroscience
Key Differentiators
Focus on women's health through brain-based innovation.
Clinical Focus
Women's Health
Company Info
- Business Model
- Hybrid
- Total Funding
- 7,300,000
- Website
- samphireneuro.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
WIND trial (double-blind, placebo-controlled): 72% clinically significant pain relief (53% avg reduction), 67% mood/function improvement. CE-marked. FDA clearance pending. Multi-site trials at UCL, Monash, Stanford.
MedStartr Index Score
?What do you think of Samphire Neuroscience?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.